Haemonetics | HAE - Ebit

Stock Price
56.29
Daily Change
-0.83 -1.45%
Monthly
-6.36%
Yearly
-19.94%
Q2 Forecast
55.16

Haemonetics reported $67.4M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Avanos Medical USD 8.9M 15.87M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Cerus USD -1.45M 488K Dec/2024
Cooper Companies USD 212.8M 72.4M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 268M 395M Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 67.4M 13.71M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
Masimo USD 77.4M 6.5M Mar/2026
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Quidel USD -27.4M 9.9M Mar/2026
ResMed USD 505.67M 8.07M Mar/2026
STAAR Surgical USD 17.4M 28.34M Mar/2026
Steris USD 318.7M 40.7M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Surmodics USD 58K 380K Jun/2025
Teleflex USD 37.03M 686K Mar/2026
Terumo JPY 43.88B 1.21B Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
US Physical Therapy USD 12.41M 4.35M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026